Agile Devices is a technology company.
Agile Devices has raised $1.0M across 1 funding round.
Agile Devices has raised $1.0M in total across 1 funding round.
Agile Devices has raised $1.0M in total across 1 funding round.
Agile Devices's investors include Archangel Network of Funds, Launchpad Venture Group.
Agile Devices is a medical technology company specializing in advanced interventional devices, primarily the Angler® deflectable microcatheter. This product is designed for peripheral and coronary vascular interventions, offering clinicians enhanced maneuverability through an actively controlled deflectable tip. By enabling quicker vessel navigation and reducing the need for guidewire and catheter exchanges, Agile Devices aims to decrease procedure time and costs, improve operating room availability, and most importantly, enhance patient outcomes[1][3]. The company serves interventional radiologists and vascular specialists who face challenges navigating complex vascular anatomies during procedures.
Agile Devices was founded with the goal of addressing the limitations of existing microcatheters, particularly the lack of active tip control which often leads to longer procedures and increased risks. While specific founding year and founder details are not explicitly stated in the available information, the company has developed patented coaxial deflection technology that emerged from the need to improve clinical outcomes in vascular interventions. Early prototypes demonstrated superior performance in preclinical models, successfully navigating complex vascular targets faster than existing devices, marking pivotal validation moments for the technology[1].
Agile Devices is riding the trend of increasing demand for minimally invasive, precision-guided vascular interventions. The timing is critical as the healthcare industry seeks technologies that improve procedural efficiency and patient safety while managing rising costs. Market forces such as aging populations and the prevalence of vascular diseases drive the need for innovative catheter technologies. Agile Devices influences the broader ecosystem by pushing forward the capabilities of interventional tools, potentially setting new standards for catheter maneuverability and procedural outcomes[1][3].
Looking ahead, Agile Devices is positioned to expand adoption of its deflectable microcatheter technology as clinical validation progresses and regulatory approvals advance. Trends such as personalized medicine and robotic-assisted interventions may further enhance the relevance of actively steerable devices. The company’s influence is likely to grow as it demonstrates improved clinical outcomes and cost-effectiveness, potentially becoming a key player in the interventional radiology device market. Continued innovation and integration with emerging procedural technologies will shape its trajectory, reinforcing its role in transforming vascular intervention practices[1][3].
Agile Devices has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Venture Round in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2021 | $1.0M Venture Round | Archangel Network of Funds, Launchpad Venture Group |